BIOSPECIFICS TECHNOLOGIES CORP·4

Aug 17, 7:48 PM ET

Wegman Toby 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 17, 2018

Insider Transaction Report

Form 4
Period: 2018-08-17
Wegman Toby
Director10% Owner
Transactions
  • Sale

    Common Stock, $0.001 par value

    2018-08-17$51.89/sh2,500$129,728947,473 total(indirect: See footnote)
Footnotes (2)
  • [F1]The selling price of $51.8912 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.8641 to $52.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES